2023 Partners

Image Credit: Nucleus RadioPharma

Nucleus Radiopharma

Hosting Partner

Nucleus RadioPharma is the first fully integrated radiopharmaceutical CDMO and supply chain network that will ensure cancer patients can access potentially life-saving radiopharmaceuticals. Founded by Eclipse Ventures and Mayo Clinic in late 2022, Nucleus was built to help advance the clinical development, manufacturing, and supply chain of these therapies. The first of our multiple U.S. facilities under construction will open in late 2023 in Rochester, Minnesota adjacent to the Mayo Clinic.

To learn more, visit www.nucleusrad.com

gold logo blue lettering (003)

Radioisotope Life Sciences (RLS)

Exhibition Partner

RLS (Radioisotope Life Sciences) Inc., the nation’s only accredited nuclear pharmacy group, and the third-largest nuclear medicine pharmacy network in the United States, owns and operates 31 radiopharmacies across 18 states, offering an extensive portfolio of molecular imaging products. We endeavor to supply the highest quality radiopharmaceuticals in the industry by dispensing 100 percent of injectable unit dose products in clean rooms built to ISO 1644-1 specifications. In support of our commitment to quality, we provide tailored solutions and exceptional service to our more than 1500 customers.



AtomVie Global Radiopharma

Exhibition Partner

AtomVie Global Radiopharma Inc. (AtomVie) is a global leading CDMO for the GMP manufacturing and global distribution of clinical and commercial radiopharmaceuticals. Building upon the expertise and high-quality services since 2008 from the Centre for Probe Development and Commercialization (CPDC), AtomVie offers the full range of scientific, technical, regulatory, quality, logistics and business expertise combined with a specialized infrastructure for the development of radiopharmaceuticals from clinical studies to the commercial marketplace. AtomVie recently closed its Series A financing allowing it to complete the buildout and setup of its new 70,000 sq. ft. purpose-built, state-of-the-art facility. The new facility, set to open in late 2024, will offer expanded clinical and commercial manufacturing of radiopharmaceuticals for all level of throughput, scalable from low to high number of doses per batch. With its reliable logistic expertise, AtomVie currently serves international clients conducting studies in over 17 countries worldwide, improving patients’ lives all over the globe.



Pacer Air Freight

Exhibition Partner

With over 30 years of experience in shipping and a global network of reliable partners, Pacer Air Freight is the go-to independent freight forwarder for safe and efficient delivery of time-critical medical products worldwide.

Pacer's end-to-end understanding of the shipping process when it comes to medical devices, supplies, and radioactive isotopes is what sets us apart. We anticipate and eliminate potential bottlenecks, using cutting-edge technology, tracking management software, and personalized customer service available 24/7.

Our in-depth understanding of transportation regulations, our customized solutions which include warehousing and packaging, and our customer-centric approach is how we contribute to the availability of new treatments for patients worldwide.

We are an ISO 9001 Certified company and a Regulated Agent as part of Transport Canada's Air Cargo Security program.




Event Partner

Curium is the world’s largest nuclear medicine company. We develop, manufacture and distribute world-class radiopharmaceutical products to help patients around the globe. Our proven heritage combined with a pioneering approach are the hallmarks to deliver innovation, excellence and unparalleled service.

To learn more, visit curiumpharma.com


Northstar Medical Radioisotopes

Event Partner

NorthStar's Radiopharmaceutical CDMO/CMO unit offers customized services and expertise to accelerate biopharmaceutical companies' development and commercialization programs. The NorthStar CDMO is the first and only U.S. facility providing commercial-scale, multi-radioisotope production and radiopharmaceutical development on-site. With a 52,000 sq. ft. footprint, it sets new industry standards, serving the growing therapeutic and diagnostic radiopharmaceuticals market. Our facility effectively supports the entire product lifecycle, with cGMP and radiation safety programs to ensure high-quality and safe practices.